MedImmune says swine flu vaccine ready end-Sept
WASHINGTON (Reuters) - MedImmune's inhaled vaccine against the pandemic H1N1 virus could be ready to start shipping to the U.S. government by the end of September, a company official said on Thursday.
MedImmune's Dr. Raburn Mallory said the company, a unit of AstraZeneca, has submitted safety data for their nasal spray swine flu vaccine to the U.S. Food and Drug Administration.
"There are no red flags there. We think we can have 5 million doses ready to distribute at the end of September," Mallory said in an interview. U.S. officials had not expected vaccination to begin until mid-October.
(Editing by Sandra Maler)
- Tweet this
- Share this
- Digg this
- Israel extends Gaza ceasefire for 24 hours, Hamas rejects terms
- Australia approves Adani's $16 bln Carmichael coal project
- U.S. diplomats' return to Libya could be more hazardous than exit
- Analysis - Amazon's far-reaching ambitions, lack of profits, unnerve investors
- Reliance Power to buy Jaiprakash's hydropower business
Encephalitis in India
Almost 570 people in India have died after contracting encephalitis, commonly known as "brain fever", health authorities said on Friday, warning the death toll may rise with more people still at risk. Full Article